Global Patent Index - EP 1011440 A1

EP 1011440 A1 2000-06-28 - VACCINE AGAINST LIPOPOLYSACCHARIDE CORE

Title (en)

VACCINE AGAINST LIPOPOLYSACCHARIDE CORE

Title (de)

IMPFSTOFF GEGEN DEN KERN VON LIPOPOLYSACCHARIDEN

Title (fr)

VACCIN DIRIGE CONTRE LES NOYAUX DE LIPOPOLYSACCHARIDES

Publication

EP 1011440 A1 (EN)

Application

EP 98922339 A

Priority

  • US 9809988 W
  • US 4668097 P

Abstract (en)

[origin: WO9851217A1] Complete core LPS (lacking O-polysaccharide side chains) from Gram-negative bacteria are incorporated into a vaccine typically in liposomes. The complete core of E. coli K 12 is particularly useful. Upon administration to a mammal the vaccine stimulates synthesis of antibodies which are cross-protective against smooth and rough forms of LPS from at least two different Gram-negative bacterial strains having different core structures.

IPC 1-7 (main, further and additional classification)

A61B 5/055; A61K 39/02; A61K 39/108; A61K 39/112; A61K 39/40; A61K 51/00; C07K 16/00

IPC 8 full level (invention and additional information)

A61K 9/127 (2006.01); A61K 39/02 (2006.01); A61K 39/102 (2006.01); A61K 39/108 (2006.01); A61K 39/112 (2006.01); A61K 39/295 (2006.01); A61K 39/39 (2006.01); A61K 47/02 (2006.01); A61P 39/02 (2006.01)

CPC (invention and additional information)

A61K 39/0275 (2013.01); A61K 2039/55555 (2013.01)

Designated contracting state (EPC)

BE CH DE DK ES FR GB GR IE IT LI NL PT SE

EPO simple patent family

WO 9851217 A1 19981119; AU 7491298 A 19981208; CA 2289760 A1 19981119; EP 1011440 A1 20000628; EP 1011440 A4 20030806; JP 2001527562 A 20011225

INPADOC legal status


2007-01-10 [18D] DEEMED TO BE WITHDRAWN

- Effective date: 20060704

2003-08-06 [A4] SUPPLEMENTARY SEARCH REPORT

- Effective date: 20030623

2000-06-28 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 19991216

2000-06-28 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A1

- Designated State(s): BE CH DE DK ES FR GB GR IE IT LI NL PT SE